What it is used for

VAQTA is indicated for active pre-exposure prophylaxis against disease caused by hepatitis A virus in persons 12 months of age and older. Primary immunisation should be given at least 2 weeks prior to expected exposure to Hepatitis A virus. Individuals who are or will be increased risk of infection include: Travellers to areas of intermediate or high endemicity for hepatitis A. Persons for whom Hepatitis A is an occupational hazard. Employee of child day-care centers. Certain institutional workers (eg. caretakers for the intellectually disabled). Health workers and teachers in remote Aboriginal and Torres Strait Islander communities. Nursing staff and other health care workers in contact with patients in paediatric wards and infectious disease wards. Sewerage workers. Recipients of blood products. Individuals with chronic liver disease and those who have had a liver transplant. Homosexually active males. Human Immunodeficiency Virus (HIV)-infected Adults.

How to take it

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

• The way to take this medicine: Intramuscular
• Store at 2 to 8 degrees Celsius
• Do not Freeze
• Lifetime is 3 Years.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Slightly opaque white suspension.

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.

Is this medicine subsidised?

This medicine may be subsidised which may make it cheaper. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy?

For the active ingredient hepatitis a vaccine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.